16/03/2025
A contraceptive pill, endometriosis treatment and an IVF drug will be made cheaper to access, in the latest round of women’s health funding announced by the Albanese government.
The government will fund several additions to the Pharmaceutical Benefits Scheme (PBS), including the contraceptive pill ‘Slinda’ which is a progestogen-only pill, and the new endometriosis treatment Ryeqo.
Both those drugs will be listed on the PBS from May 1, following recommendations by the Pharmaceutical Benefits Advisory Council.
Over 100,000 Australian women are expected to benefit from the listing of the Slinda pill each year, who without subsidy, might pay more than $250 for a year of treatment. The drug Ryeqo, which is a relatively new pain treatment for endometriosis, currently costs up to $2,700 for a year’s supply.